Atlas Trials

Study to Evaluate Safety, Immunogenicity and Efficacy of PfSPZ Vaccine in HIV Negative and HIV Positive Tanzanian Adults

Clinical trial NCT03420053 · COMPLETED

Trial details

NCT number
NCT03420053
Sponsor
Sanaria Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
MalariaMalaria,Falciparum
Start date
2018-02-07
Primary completion
2018-08-25
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.